Anti Viral Protocol

Oftentimes, a Lyme patient may not take into consideration that attending viruses, such as Epstein Barr or CMV, can be affecting the progress of their treatments. The Anti Viral Protocol addresses just that. An Anti-metabolic agent is used as an RNA polymer and nucleotide inhibitor, possessing a high Anti-viral activity, acting as well by partial inhibition of Viral DNA synthesis. This in turn prevents Viral replication just at the lowest dose necessary to sensitize organisms for photo-exposure, from which such cyclic molecules absorbs a photon, and one of its electrons is promoted into a higher energy (elevating it into S0, a short lived electronically excited stage, followed by apoptosis, as photochemotherapy combined therapy). We prolong the anti-metabolic agent’s medium half life by applying it at 4 drops per minute and in some cases for 24 hours straight, allowing a maximum anti virus replication effect, followed by photo exposure. (Each dose, anti-metabolic agent selection and exposure time is case dependent).